FDA Approves New Use for Cancer Drug Lenalidomide

The FDA has expanded the existing indication for lenalidomide in combination with dexamethasone to include patients newly diagnosed with multiple myeloma. Lenalidomide plus dexamethasone was previously approved in 2006 for use in multiple myeloma patients who had received at least one prior therapy.

http://ift.tt/1vGSqIe